AUTL
Autolus Therapeutics
AUTL
AUTL
94 hedge funds and large institutions have $261M invested in Autolus Therapeutics in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
34% less capital invested
Capital invested by funds: $395M → $261M (-$134M)
40% less call options, than puts
Call options by funds: $87K | Put options by funds: $145K
61% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 23
Holders
94
Holding in Top 10
2
Calls
$87K
Puts
$145K
Top Buyers
| 1 | +$5.63M | |
| 2 | +$2.79M | |
| 3 | +$2.71M | |
| 4 |
Axa
Paris,
France
|
+$2.02M |
| 5 |
Renaissance Technologies
New York
|
+$1.5M |
Top Sellers
| 1 | -$8.48M | |
| 2 | -$3.93M | |
| 3 | -$2.43M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$2.26M |
| 5 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$1.25M |
